Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer by Masuda Norikazu, Iwata Hiroji, Nakamura Seigo, Ohno Shinji, Tan Yuping, Jin Xueguang, Winslow John, Saji Shigehira, Huang Weidong, Sperinde Jeff, Toi Masakazu, Aogi Kenjiro, Morita Satoshi, Petropoulos Christos, Bates Michael

Get full text

Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer by Iwata, Hiroji, Masuda, Norikazu, Kim, Sung-Bae, Inoue, Kenichi, Rai, Yoshiaki, Fujita, Takashi, Chiu, Joanne, Ohtani, Shoichiro, Takahashi, Masato, Miyaki, Toshiko, Lu, Yen-Shen, Xu, Binghe, Yap, Yoon Sim, Bustam, Anita Zarina, Yao, Bin, Zhang, Bo, Bryce, Richard, Chan, Arlene